Company / Current Assets per Share
ArriVent BioPharma, Inc. Current Assets per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$7.21
FY2024
5-year range
$7.21 / $74.72
FY2023-FY2024
Trend
-90.3%
vs FY2023
Sector context
#102 of 210
Health Care
What the data says
At $7.21, ArriVent BioPharma, Inc.'s current assets per share ranks #102 of 210 in the Health Care sector.
Based on SEC 10-K filings.
7.21 in FY2024.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#102 of 210 in Health CareTop 49% of 210This company $7.21 Sector average $170.65
▼
-95.8% below sector average
Key checks
Key Insights
- In FY2024, current assets per share decreased 90.3% year-over-year.
- Ranks #102 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $7.21 | -90.3% |
| FY2023 | $74.72 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026